Ammonia Assay Antibodies Assay Kits Biology Cells cDNA Clia Kits Devices DNA DNA Templates Elisa Kits Equipments Ethanol Assay Kit Exosomes Gels Hat Assay Isotypes Medium & Serums Nadh Assay NATtrol Panel Pcr Kits Peptides Ria Kits RNA Sod Assay Testing Triglyceride Assay Urea Assay Kit Zinc Assay Kit
Inhibitor of DNA binding 2 (Id2) mediates microtubule polymerization in the brain by regulating αK40 acetylation of α-tubulin
Acetylation of α-tubulin lysine 40 (αK40) contributes to microtubule (MT) stability and is crucial for neuronal improvement and performance, whereas extreme αK40 deacetylation is noticed in neurodegenerative problems together with Alzheimer’s illness (AD). Right here we recognized inhibitor of DNA binding 2 (Id2) as a novel MT-binding associate that interacts with α-tubulin and enhances αK40 acetylation, resulting in MT polymerization within the neurons. Commensurate with our discovering that the low ranges of Id2 expression together with a decreased αK40 acetylation within the postmortem human AD affected person and 5X-FAD, AD mannequin mice mind, Id2 upregulation within the hippocampus of 5X-FAD, which exhibit excessive ranges of Sirt2 expression, elevated αK40 acetylation and reconstitutes axon progress. Therefore our research means that Id2 is essential for sustaining MT stability throughout neural improvement and the potential of Id2 to counteract pathogenic Sirt2 exercise in AD.
Block copolymers primarily based on ethylene and methacrylates utilizing a mixture of catalytic chain switch polymerisation (CCTP) and radical polymerization
Two scalable polymerization strategies are utilized in mixture for the synthesis of ethylene and methacrylate block copolymers. ω-Unsaturated methacrylic oligomers (MMA n ) produced by catalytic chain switch (co)polymerisation (CCTP) of methyl methacrylate (MMA) and methacrylic acid (MAA) are used as reagents within the radical polymerization of ethylene (E) in dimethyl carbonate solvent beneath comparatively gentle situations (80 bar, 70°C). Kinetic measurements and analyses of the produced copolymers by dimension exclusion chromatography (SEC) and a mixture of nuclear magnetic resonance (NMR) strategies point out that MMA n is concerned in a degradative chain switch course of ensuing within the formation of (MMA) n – b -PE block copolymers. Molecular modelling carried out by DFT helps the general reactivity scheme and noticed selectivities. The impact of MMA n molar mass and composition can also be studied. The block copolymers have been characterised by differential scanning calorimetry (DSC) and their bulk behaviour studied by SAXS/WAXS evaluation.
Fabrication of hydrophilic zwitterionic microspheres by way of inverse suspension polymerization for the enrichment of N-glycopeptides
A form of zwitterionic microsphere was ready by way of one-step inverse suspension polymerization using 3-[N,N-dimethyl-[2-(2-methylpropyl-2-enyloxy) ethyl] ammonium] propane-1-sulfonate (MSA) and N,N-methylene bisacrylamide (BIS) because the precursors. The preparation situations have been fastidiously investigated and optimized by regulating the content material of complete monomers, ratio of MSA to BIS, ratio of water to grease, and content material of stabilizer.
The properties of microspheres have been characterised by helium ion microscopy (HIM), Fourier remodel infrared spectroscopy (FT-IR), X-ray photoelectron spectroscopy (XPS), N2 adsorption/desorption measurement, and water contact angle measurement.
The particle dimension of ensuing polydisperse microspheres ranged from 15-25 μm, exhibiting excessive particular floor space of 138 m2 g-1. Owing to nice hydrophilicity, the ensuing zwitterionic microspheres may very well be straight used as hydrophilic interplay chromatography (HILIC) sorbent to complement glycopeptides from biosamples with none chemical modification. A complete of 19 N-glycopeptides was enriched from 10 μg of IgG digest.
In addition to, as much as 383 N-glycopeptides and 224 N-glycosylation websites have been unambiguously recognized from 2 μL of human serum digest by cLC-MS/MS after enrichment with zwitterionic microspheres, indicating their nice enrichment efficiency to N-glycopeptides. The method of getting ready hydrophilic zwitterionic microspheres incorporates just one synthesis response and is appropriate for large-scale preparation.
Mussel-inspired adhesive antioxidant antibacterial hemostatic composite hydrogel wound dressing by way of photo-polymerization for contaminated pores and skin wound therapeutic
With the growing prevalence of drug-resistant bacterial infections and the gradual therapeutic of chronically contaminated wounds, the event of latest antibacterial and accelerated wound therapeutic dressings has develop into a severe problem. With a purpose to remedy this drawback, we developed photo-crosslinked multifunctional antibacterial adhesive anti-oxidant hemostatic hydrogel dressings primarily based on polyethylene glycol monomethyl ether modified glycidyl methacrylate functionalized chitosan (CSG-PEG), methacrylamide dopamine (DMA) and zinc ion for disinfection of drug-resistant micro organism and selling wound therapeutic. The mechanical properties, rheological properties and morphology of hydrogels have been characterised, and the biocompatibility of those hydrogels was studied via cell compatibility and blood compatibility exams.
These hydrogels have been examined for the in vitro blood-clotting potential of entire blood and confirmed good hemostatic potential within the mouse liver hemorrhage mannequin and the mouse-tail amputation mannequin. As well as, it has been confirmed that the multifunctional hydrogels have good inherent antibacterial properties in opposition to Methicillin-resistant Staphylococcus aureus (MRSA). Within the full-thickness pores and skin defect mannequin contaminated with MRSA, the wound closure ratio, thickness of granulation tissue, variety of collagen deposition, regeneration of blood vessels and hair follicles have been measured.
The inflammation-related cytokines (CD68) and angiogenesis-related cytokines (CD31) expressed throughout pores and skin regeneration have been studied. All outcomes point out that these multifunctional antibacterial adhesive hemostatic hydrogels have higher therapeutic results than commercially out there Tegaderm™ Movie, revealing that they’ve develop into promising different within the therapeutic of contaminated wounds.
Revealing Polymerization Kinetics with Colloidal Dipatch Particles
Restricted-valency colloidal particles can self-assemble into polymeric buildings analogous to molecules. Whereas their structural equilibrium properties have attracted extensive consideration, perception into their dynamics has confirmed difficult. Right here, we examine the polymerization dynamics of semiflexible polymers in 2D by direct statement of assembling divalent particles, bonded by essential Casimir forces.
The reversible essential Casimir power creates dwelling polymerization situations with tunable chain dissociation, affiliation, and bending rigidity. We discover that in contrast to dilute polymers that present exponential dimension distributions in wonderful settlement with Flory concept, concentrated samples exhibit arrest of rotational and translational diffusion because of a steady isotropic-to-nematic transition in 2D, slowing down the expansion kinetics.
These results are circumvented by the addition of higher-valency particles, cross linking the polymers into networks. Our outcomes connecting polymer flexibility, polymer interactions, and the peculiar isotropic-nematic transition in 2D provide perception into the polymerization processes of artificial two-dimensional polymers and biopolymers at membranes and interfaces.
Controllable Frontal Polymerization and Spontaneous Patterning Enabled by Part-Altering Particles
Frontal polymerization supplies a fast, financial, and environmentally pleasant methodology to fabricate thermoset polymers and composites. Regardless of its effectivity and decreased environmental affect, the manufacturing methodology is underutilized as a result of restricted elementary understanding of its dynamic management. This work experiences the management and patterning of the entrance propagation in a dicyclopentadiene resin by immersion of phase-changing polycaprolactone particles.
Predictive and designed patterning is enabled by multiphysical numerical analyses, which reveal that the interaction between endothermic part transition, exothermic chemical response, and warmth change govern the temperature, velocity, and propagation path of the entrance by way of two completely different interplay regimes. To sample the entrance, one can range the dimensions and spacing between the particles and enhance the variety of propagating fronts, leading to tunable bodily patterns shaped because of entrance separation and merging close to the particles. Each single- and double-frontal polymerization experiments in an open mildew are carried out.
The outcomes affirm the front-particle interplay mechanisms and the shapes of the patterns explored numerically. The current research provides a elementary understanding of frontal polymerization within the presence of heat-absorbing second-phase supplies and proposes a possible one-step manufacturing methodology for exactly patterned polymeric and composite supplies with out masks, molds, or printers.
 OH-PEG-OH,400 |
|||
| HO002002-400-10g | Biochempeg | 10g | EUR 306 |
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
 FITC-PEG-Alkyne,400 |
|||
| FL044007-400-100mg | Biochempeg | 100mg | EUR 568 |
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
 SH-PEG-SH,400 |
|||
| 33-HO003003-400 | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
 COOH-PEG-COOH,400 |
|||
| 33-HO017017-400 | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
 SC-PEG-SC,400 |
|||
| 33-HO023023-400 | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
 HO-PEG-COOH,400 |
|||
| 33-HE002017-400 | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
 SH-PEG-COOH,400 |
|||
| 33-HE003017-400 | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
 HS-PEG-NHS,400 |
|||
| 33-HE003023-400 | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
 SH-PEG-Biotin,400 |
|||
| 33-HE003041-400 | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
 NH2-PEG-COOH,400 |
|||
| 33-HE005017-400 | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
){kind=tracking} TruStrip Sample Transfer Strips, 400-ul, 50/Pk (without sample tracking dye) |
|||
| STS-400-50 | Alpha Diagnostics | 1 Pk | Ask for price |
){kind=tracking} TruStrip Sample Transfer Strips, 400-ul, 50/Pk (with sample tracking dye) |
|||
| STSD-400-50 | Alpha Diagnostics | 1 Pk | Ask for price |
 SH-PEG-NH-Methoxyphenone,400 |
|||
| 33-HE003071-400 | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
 Polysucrose 400 |
|||
| abx082061-10g | Abbexa | 10 g | EUR 189 |
|
|||
 Ficoll 400 |
|||
| abx082174-50g | Abbexa | 50 g | EUR 272 |
|
|||
Polysucrose 400 |
|||
| GC7257-100G | Glentham Life Sciences | 100 g | EUR 229 |
Polysucrose 400 |
|||
| GC7257-250G | Glentham Life Sciences | 250 g | EUR 429 |
Polysucrose 400 |
|||
| GC7257-25G | Glentham Life Sciences | 25 g | EUR 102 |
Ficoll 400 |
|||
| F760014 | Bio Basic | 25g | EUR 90.02 |
|
|||
 ELISA Kit, 96 tests, Quantitative) Human Chorionic Gonadotropin (HCG) ELISA Kit, 96 tests, Quantitative |
|||
| 400 | Alpha Diagnostics | 1 kit | EUR 469 |
 Polyethylene glycol 400 |
|||
| GC3481-100G | Glentham Life Sciences | 100 g | EUR 41 |
Polyethylene glycol 400 |
|||
| GC3481-1KG | Glentham Life Sciences | 1 kg | EUR 65 |
Polyethylene glycol 400 |
|||
| GC3481-250G | Glentham Life Sciences | 250 g | EUR 46 |
Polyethylene glycol 400 |
|||
| GC3481-500G | Glentham Life Sciences | 500 g | EUR 53 |
Polyethylene glycol 400 |
|||
| GC3481-5KG | Glentham Life Sciences | 5 kg | EUR 153 |
 mPEG-CH3?400 |
|||
| 33-MF001049-400 | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
) Anti-Hex (400) |
|||
| YF-MA13442 | Abfrontier | 100 ug | EUR 363 |
|
Description: Mouse monoclonal to Hex |
|||
 Antibody) MAP3K8 (Ab-400) Antibody |
|||
| 33235-100ul | SAB | 100ul | EUR 252 |
MAP3K8 (Ab-400) Antibody |
|||
| 33235-50ul | SAB | 50ul | EUR 187 |
MAP3K8 (Ab-400) Antibody |
|||
| CSB-PA901361- | Cusabio | EUR 335 | |
|
|||
|
Description: A polyclonal antibody against MAP3K8 (Ab-400). Recognizes MAP3K8 (Ab-400) from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;WB:1:500-1:3000, IHC:1:50-1:100 |
|||
MAP3K8 (Ab-400) Antibody |
|||
| CSB-PA901361-100ul | Cusabio | 100ul | EUR 316 |
|
|||
|
Description: A polyclonal antibody against MAP3K8 (Ab-400). Recognizes MAP3K8 (Ab-400) from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;WB:1:500-1:3000, IHC:1:50-1:100 |
|||
 Antibody) Tau (pS717 / 400) Antibody |
|||
| abx218901-100ug | Abbexa | 100 ug | EUR 439 |
|
|||
 Alu I unit: 400 |
|||
| YRALU1 | Yeastern Biotech | 1 vial | Ask for price |
 Bcl I unit: 400 |
|||
| YRBCL1 | Yeastern Biotech | 1 vial | Ask for price |
 Bsp1286 I unit: 400 |
|||
| YRBSP1286 | Yeastern Biotech | 1 vial | Ask for price |
 Nco I unit: 400 |
|||
| YRNCO1 | Yeastern Biotech | 1 vial | Ask for price |
 Not I unit: 400 |
|||
| YRNOT1 | Yeastern Biotech | 1 vial | Ask for price |
 Ssp I unit: 400 |
|||
| YRSSP1 | Yeastern Biotech | 1 vial | Ask for price |
 Antibody) Tau (Ab-717/400) Antibody |
|||
| 33223-100ul | SAB | 100ul | EUR 252 |
Tau (Ab-717/400) Antibody |
|||
| 33223-50ul | SAB | 50ul | EUR 187 |
 Antibody) Tau (Phospho-Ser717/400) Antibody |
|||
| 12486-100ul | SAB | 100ul | EUR 252 |
Tau (Phospho-Ser717/400) Antibody |
|||
| 12486-50ul | SAB | 50ul | EUR 187 |
 100 G POLYSUCROSE 400, POWDER |
|||
| 61-196-RM | CORNING | 100 g/pk | EUR 256 |
|
Description: Specialty Media; Insect Media Products |
|||
 500 G POLYSUCROSE 400, POWDER |
|||
| 61-196-RO | CORNING | 500 g/pk | EUR 507 |
|
Description: Specialty Media; Insect Media Products |
|||
 DiagNano Silica Particles, 400 nm |
|||
| DNG-B008 | Creative Diagnostics | 10 mL | EUR 559 |
 Antibody) MAPT (Ab-717/400) Antibody |
|||
| CSB-PA112612- | Cusabio | EUR 335 | |
|
|||
|
Description: A polyclonal antibody against MAPT (Ab-717/400). Recognizes MAPT (Ab-717/400) from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:3000 |
|||
MAPT (Ab-717/400) Antibody |
|||
| CSB-PA112612-100ul | Cusabio | 100ul | EUR 316 |
|
|||
|
Description: A polyclonal antibody against MAPT (Ab-717/400). Recognizes MAPT (Ab-717/400) from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:3000 |
|||
) Polyclonal TFG Antibody (aa350-400) |
|||
| APR02435G | Leading Biology | 0.05mg | EUR 484 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human TFG (aa350-400). This antibody is tested and proven to work in the following applications: |
|||
) Polyclonal SNX2 Antibody (aa350-400) |
|||
| AMM07912G | Leading Biology | 0.05mg | EUR 484 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human SNX2 (aa350-400). This antibody is tested and proven to work in the following applications: |
|||
) Bromoacetyl resin (200-400 mesh) |
|||
| D-2555.0001 | Bachem | 1.0g | EUR 139 |
Bromoacetyl resin (200-400 mesh) |
|||
| D-2555.0005 | Bachem | 5.0g | EUR 441 |
 9998 SCREW CAP 400/24 |
|||
| 9998-24 | CORNING | 12/pk | EUR 54 |
|
Description: General Apparatus; Stoppers |
|||
 9999 CAP ONLY 400/24 |
|||
| 9999-24 | CORNING | 12/pk | EUR 50 |
|
Description: General Apparatus; Stoppers |
|||
) Polyclonal ALDH3A2 Antibody (aa166-400) |
|||
| APG01760G | Leading Biology | 0.05mg | EUR 484 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human ALDH3A2 (aa166-400). This antibody is tested and proven to work in the following applications: |
|||
) Polyclonal PLEKHA8 Antibody (aa122-400) |
|||
| AMM07243G | Leading Biology | 0.05ml | EUR 484 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human PLEKHA8 (aa122-400). This antibody is tested and proven to work in the following applications: |
|||
 Conjugated Antibody) MAP3K8 (Ab-400) Conjugated Antibody |
|||
| C33235 | SAB | 100ul | EUR 397 |
) Polyclonal NPY2R Antibody (aa350-400) |
|||
| APR08798G | Leading Biology | 0.05mg | EUR 484 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human NPY2R (aa350-400). This antibody is tested and proven to work in the following applications: |
|||
 Antibody) Phospho-Tau (Ser717/400) Antibody |
|||
| AF8129 | Affbiotech | 200ul | EUR 376 |
|
Description: Tau (Phospho-Ser717/400) Antibody detects endogenous levels of Tau only when phosphorylated at Ser717/400. |
|||
) Polyclonal GHRHR Antibody (aa351-400) |
|||
| AMM05905G | Leading Biology | 0.05ml | EUR 484 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human GHRHR (aa351-400). This antibody is tested and proven to work in the following applications: |
|||
 Antibody) Tau (Phospho- Ser717/400) Antibody |
|||
| ABF8129 | Lifescience Market | 100 ug | EUR 438 |
 antibody) Anti-OXER1 (aa389-400) antibody |
|||
| STJ72566 | St John's Laboratory | 100 µg | EUR 359 |
 Trypsin/Chrmotrypsin Complex 2400:400 |
|||
| T6789 | Bio Basic | 5g | EUR 89.15 |
|
|||
) Methoxy PEG Maleimide linear (MW: 10,000) |
|||
| PEG-10K | Alpha Diagnostics | 100 mg | EUR 225 |
) Methoxy PEG Maleimide lbranched (MW: 40,000) |
|||
| PEG-40K | Alpha Diagnostics | 100 mg | EUR 225 |
) Methoxy PEG Maleimide linear (MW: 5,000) |
|||
| PEG-5K | Alpha Diagnostics | 100 mg | EUR 225 |
) Polyclonal RNF216 / TRIAD3 Antibody (aa350-400) |
|||
| APR02481G | Leading Biology | 0.05mg | EUR 484 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human RNF216 / TRIAD3 (aa350-400). This antibody is tested and proven to work in the following applications: |
|||
) Polyclonal MAPK3 / ERK1 Antibody (aa350-400) |
|||
| APR02823G | Leading Biology | 0.05mg | EUR 484 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human MAPK3 / ERK1 (aa350-400). This antibody is tested and proven to work in the following applications: |
|||
) Polyclonal HSPD1 / HSP60 Antibody (aa350-400) |
|||
| APR16775G | Leading Biology | 0.05mg | EUR 484 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human HSPD1 / HSP60 (aa350-400). This antibody is tested and proven to work in the following applications: |
|||
 - 400 ul) CLOuD9 Inducer Reagent (0.5M) - 400 ul |
|||
| CASCL9-200A-1 | SBI | 200 ul | EUR 370 |
|
|||
) Polyclonal PPP1R10 / PNUTS Antibody (aa350-400) |
|||
| APR12938G | Leading Biology | 0.05ml | EUR 484 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human PPP1R10 / PNUTS (aa350-400). This antibody is tested and proven to work in the following applications: |
|||
) Polyclonal PH / PAH Antibody (aa351-400) |
|||
| APR09103G | Leading Biology | 0.05ml | EUR 484 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human PH / PAH (aa351-400). This antibody is tested and proven to work in the following applications: |
|||
 Blocking Peptide) Phospho-Tau (Ser717/400) Blocking Peptide |
|||
| AF8129-BP | Affbiotech | 1mg | EUR 195 |
) Polyclonal AGER / RAGE Antibody (aa350-400) |
|||
| AMM05591G | Leading Biology | 0.05mg | EUR 484 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human AGER / RAGE (aa350-400). This antibody is tested and proven to work in the following applications: |
|||
 Serological Pipettes, 5ml, 400 per case |
|||
| SP102116 | Bio Basic | 1CS, 400UNIT | EUR 179.94 |
|
|||
 Serological Pipettes, 10ml, 400 per case |
|||
| SP102121 | Bio Basic | 1CS, 400UNIT | EUR 157.61 |
|
|||
 Cellufine GCL-2000HF |
|||
| 21-400 | JNC America | 100 ml | EUR 302 |
) Jurkat Cell Extract (Uninduced) |
|||
| 1106-400 | Biovision | EUR 185 | |
) Jurkat Cell Extract (Induced) |
|||
| 1107-400 | Biovision | EUR 185 | |
 AMV Reverse Transcriptase |
|||
| 105-400 | GeneOn | 200 units | EUR 63 |
 Dilution Buffer |
|||
| 1066-400 | Biovision | EUR 262 | |
 Cell Lysis Buffer |
|||
| 1067-400 | Biovision | EUR 294 | |
 BEAKER,400ML,PLASTIC,LOW FORM,PP,6/6 |
|||
| 1000P-400 | CORNING | 6/pk | EUR 50 |
|
Description: Reusable Plastics; Resuable Beakers |
|||
 Cellufine MAX S-h |
|||
| 20-400 | JNC America | 100 ml | EUR 382 |
 1Kb PCR Ranger DNA Marker, 750bp-To-20Kb |
|||
| D1109-400 | GenDepot | 4x1ml | EUR 388 |
 Factor X, Human Plasma |
|||
| 7688-400 | Biovision | EUR 370 | |
 Factor Xa, Human Plasma |
|||
| 7689-400 | Biovision | EUR 408 | |
 EnzyChrom Kinase Assay Kit |
|||
| EKIN-400 | BioAssay Systems | 400 | EUR 297 |
|
Description: Rapid mix-and-measure procedure for determination of kinase activity and high-throµghput screening for kinase inhibitors by fluorimetric (530nm/590nm) method. Procedure: 10 min. Kit size: 400 tests. Detection limit: 0.01 U/L. Shelf life: 6 months. Shippin |
|||
 SEALING FILM, FOR 96 AND 384 WELL MICROPLATES, RAYON, 50 µM, BREATHABLE, NONSTERILE, BULK |
|||
| BF-400 | CORNING | 100/pk | EUR 506 |
|
Description: Sealing Products; Sealing films - Axygen |
|||
 pAAV-GFP Control Vector |
|||
| AAV-400 | Cell Biolabs | 10 µg | EUR 566 |
|
Description: Use this control vector to co-transfect along with AAV packaging vectors to produce a recombinant AAV control. |
|||
 PLATEMAX PEELABLE HEAT SEALING FILM FOR COMPOUND STORAGE. 100/500 |
|||
| HS-400 | CORNING | 100/pk | EUR 304 |
|
Description: Sealing Products; Sealing films - Axygen |
|||
 dATP, dCTP, dGTP, dTTP |
|||
| K6011100-400 | Biochain | 4x400 ul (100 mM) | EUR 235 |
|
Description: Premade ready to use kits will always come in handy. Get your experiment done right form the first try by using a validated kit with perfectly balanced reagents proportions and compatibility and by following a clear protocol. |
|||
 dATP |
|||
| K6011101-400 | Biochain | 400 ul (100 mM) | EUR 116 |
|
Description: Premade ready to use kits will always come in handy. Get your experiment done right form the first try by using a validated kit with perfectly balanced reagents proportions and compatibility and by following a clear protocol. |
|||
 dGTP |
|||
| K6011102-400 | Biochain | 400 ul (100 mM) | EUR 116 |
|
Description: Premade ready to use kits will always come in handy. Get your experiment done right form the first try by using a validated kit with perfectly balanced reagents proportions and compatibility and by following a clear protocol. |
|||
 dCTP |
|||
| K6011103-400 | Biochain | 400 ul (100 mM) | EUR 116 |
|
Description: Premade ready to use kits will always come in handy. Get your experiment done right form the first try by using a validated kit with perfectly balanced reagents proportions and compatibility and by following a clear protocol. |
|||
 dTTP |
|||
| K6011104-400 | Biochain | 400 ul (100 mM) | EUR 116 |
|
Description: Premade ready to use kits will always come in handy. Get your experiment done right form the first try by using a validated kit with perfectly balanced reagents proportions and compatibility and by following a clear protocol. |
|||
 dNTP Mix |
|||
| K6011105-400 | Biochain | 400 ul (10 mM each) | EUR 116 |
|
Description: Premade ready to use kits will always come in handy. Get your experiment done right form the first try by using a validated kit with perfectly balanced reagents proportions and compatibility and by following a clear protocol. |
|||
 Activity Assay Kit (384-Well)) EZScreen? Alanine Aminotransferase (ALT or SGPT) Activity Assay Kit (384-Well) |
|||
| K941-400 | Biovision | EUR 566 | |
) EZScreen? Triglyceride Quantification Colorimetric Assay Kit (384-well) |
|||
| K952-400 | Biovision | EUR 626 | |
) EZScreen? Lactate Dehydrogenase Activity Colorimetric Assay Kit (384-well) |
|||
| K953-400 | Biovision | EUR 555 | |
